학술논문
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
Document Type
Article
Author
Source
In The Lancet Oncology May 2017 18(5):623-630
Subject
Language
ISSN
1470-2045